본문

서브메뉴

Bridging Racial Health Disparities: Advancing Health Equity Through the Incorporation of Functional Assay Insights.
Bridging Racial Health Disparities: Advancing Health Equity Through the Incorporation of F...
Contents Info
Bridging Racial Health Disparities: Advancing Health Equity Through the Incorporation of Functional Assay Insights.
Material Type  
 학위논문
 
0017164938
Date and Time of Latest Transaction  
20250211153105
ISBN  
9798384092193
DDC  
610
Author  
Diabate, Mariame Diabate.
Title/Author  
Bridging Racial Health Disparities: Advancing Health Equity Through the Incorporation of Functional Assay Insights.
Publish Info  
[S.l.] : The Ohio State University., 2024
Publish Info  
Ann Arbor : ProQuest Dissertations & Theses, 2024
Material Info  
177 p.
General Note  
Source: Dissertations Abstracts International, Volume: 86-04, Section: B.
General Note  
Includes supplementary digital materials.
General Note  
Advisor: Parvin, Jeffrey.
학위논문주기  
Thesis (Ph.D.)--The Ohio State University, 2024.
Abstracts/Etc  
요약BRCA1 pathogenic variants are well-established risk factors for hereditary breast and ovarian cancer (HBOC). The increasing accessibility and affordability of genetic testing have led to the identification of individuals with BRCA1 variants of uncertain significance (VUS), creating a clinical challenge due to the rarity of these variants. This issue disproportionately affects women from minority backgrounds, who often face a high prevalence of VUS in their genetic screening results. The American College of Medical Geneticists (ACMG) guidelines stipulate that clinical recommendations cannot be made until these VUS are reclassified, leaving many individuals stranded in the healthcare system without access to advancements in preventive medicine.To address this gap, ACMG has permitted the use of functional assays to experimentally assess the effects of BRCA1 variants. This dissertation aims to identify the genetic and environmental factors contributing to the gaps in care for minority women dealing with HBOC, redesign the analysis pipeline for multiplexed DNA repair assays, introduce a novel multiplexed repair assay based on cisplatin resistance (CR), and adapt this pipeline to functional limited datasets.Our research successfully functionally characterized 2271 variants from the carboxy terminus for homology-directed repair function (HDR) and 1427 variants for CR. Notably, we observed consistent results between the two multiplexed functional assays, especially for non-functional variants located within critical regions of the BRCA1 protein essential for tumor suppression. Variants classified in the multiplex HDR assay exhibited 81% specificity and 93% sensitivity, while those in the multiplex CR assay demonstrated 100% specificity and 86% sensitivity. Furthermore, the functional categorizations of the variants correlated with known clinical significance and other BRCA1 functional assays.Utilizing the redesigned analysis pipeline, we reanalyzed previously published multiplexed HDR results for amino-terminus variants, providing functional insights for 2172 variants. We also compared our functional classifications to clinical interpretations, enabling variants classified as functionally normal to be applied as BS3 strong and those classified as LOF as PS3 moderate.Applying our analysis pipeline to functionally classify the limited datapoints in the coiled-coil domain of BRCA1, we provided 330 functional classifications for variants in this region. Notably, when compared to ClinVar's designated benign or likely benign and pathogenic or likely pathogenic variants, our multiplexed assay demonstrated 100% specificity and 100% sensitivity.The functional classification of 4773 BRCA1 variants presented in this dissertation offers a valuable solution to bridge the diagnostic gap in the care cascade for the treatment of breast and ovarian cancer. It is our hope that clinicians can utilize this information to better inform all patients about the risks associated with HBOC variants, ultimately leading to an improved quality of life for those affected by these genetic variants.
Subject Added Entry-Topical Term  
Medicine.
Subject Added Entry-Topical Term  
Public health.
Subject Added Entry-Topical Term  
Cellular biology.
Subject Added Entry-Topical Term  
Biomedical engineering.
Subject Added Entry-Topical Term  
Health sciences.
Subject Added Entry-Topical Term  
Information science.
Index Term-Uncontrolled  
Breast and ovarian cancer
Index Term-Uncontrolled  
RING domain
Index Term-Uncontrolled  
Functional classifications
Index Term-Uncontrolled  
Homology directed repair
Index Term-Uncontrolled  
Health disparities
Index Term-Uncontrolled  
Care cascade
Added Entry-Corporate Name  
The Ohio State University Biomedical Sciences
Host Item Entry  
Dissertations Abstracts International. 86-04B.
Electronic Location and Access  
로그인을 한후 보실 수 있는 자료입니다.
Control Number  
joongbu:655932
New Books MORE
최근 3년간 통계입니다.

Detail Info.

  • Reservation
  • 캠퍼스간 도서대출
  • 서가에 없는 책 신고
  • My Folder
Material
Reg No. Call No. Location Status Lend Info
TQ0031954 T   원문자료 열람가능/출력가능 열람가능/출력가능
마이폴더 부재도서신고

* Reservations are available in the borrowing book. To make reservations, Please click the reservation button

해당 도서를 다른 이용자가 함께 대출한 도서

Related books

Related Popular Books

도서위치